Broadview Advisors’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-24,175
Closed -$2.52M 103
2017
Q3
$2.52M Sell
24,175
-79,625
-77% -$7.82M 0.37% 73
2017
Q2
$9.86M Buy
103,800
+33,400
+47% +$2.98M 1.46% 22
2017
Q1
$6.33M Buy
70,400
+41,650
+145% +$3.64M 0.87% 52
2016
Q4
$2.26M Buy
+28,750
New +$2.16M 0.3% 73
2015
Q2
Sell
-48,600
Closed -$2.71M 101
2015
Q1
$2.71M Sell
48,600
-86,900
-64% -$4.92M 0.27% 78
2014
Q4
$8.13M Sell
135,500
-138,800
-51% -$8.11M 0.83% 56
2014
Q3
$16.1M Buy
274,300
+1,200
+0.4% +$73.9K 1.75% 19
2014
Q2
$17.6M Sell
273,100
-47,250
-15% -$2.87M 1.71% 13
2014
Q1
$17.8M Buy
320,350
+3,300
+1% +$176K 1.78% 13
2013
Q4
$17.5M Buy
317,050
+43,975
+16% +$2.44M 1.89% 12
2013
Q3
$14.4M Hold
273,075
1.67% 18
2013
Q2
$12.2M Buy
+273,075
New +$12.8M 1.72% 16

Other funds holding CE

Broadview Advisors's CE Position: Q4 2017 in Review

Broadview Advisors sold out of Celanese (CE) in Q4 2017, closing a stake of 24,175 shares — an estimated $2.52M sold.

Broadview Advisors first reported a position in CE in Q2 2013 and held it in 12 quarters. The position peaked at $17.8M in Q1 2014. 510 funds tracked by Wall St. Rank hold CE as of Q4 2017.

  • Broadview Advisors reported no remaining Celanese position as of Q4 2017 after selling out during the quarter.
  • Broadview Advisors sold 24,175 Celanese shares in Q4 2017, an estimated $2.52M.
  • Broadview Advisors first reported a position in Celanese in Q2 2013 and held it in 12 quarters.
  • Broadview Advisors's Celanese position peaked at $17.8M in Q1 2014.
  • 510 funds tracked by Wall St. Rank held Celanese as of Q4 2017.

Based on Broadview Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.